ELI LILLY & Co — Director's Dealing 2026

Feb 11, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-09

Reporting Person: Van Naarden Jacob (EVP,Pres LLY Oncology&HdCorpBD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-09	Common Stock	A	4865.888	$1044.67	Acquired	26626.498	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4342	Indirect
Common Stock	5302	Indirect

Footnotes

F1: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: On February 5, 2026, the Reporting Person's spouse transferred 5,302 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person is the trustee and a beneficiary. The transfer included 1,000 spouse-held shares previously reported as directly held due to an administrative error.